1-20 of 77
A Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nivolumab in Relapsed or Refractory Primary CNS Lymphoma: Multicenter, Retrospective Study

Jun Ho Yi, Seok Jin Kim, Sang A Kim, Jongheon Jung, Dok Hyun Yoon
Journal: Blood
Blood (2023) 142 (Supplement 1): 1772.
https://doi.org/10.1182/blood-2023-186554
Published: 2023
Journal Articles

Real-World Efficacy and Safety of Letermovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis at a Single Center

Sang-A Kim, Ji Yun Lee, Soo-Mee Bang, Jeong-Ok Lee
Journal: Blood
Blood (2023) 142 (Supplement 1): 6970.
https://doi.org/10.1182/blood-2023-188410
Published: 2023
Journal Articles

Coexpression of Tim-3 and PD-1 of T Lymphocytes Prevents Acute Graft-Versus-Host Disease

Jeong-A Kim, Jinhang Kim, Saetbyeol Kim, Misuk Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4796.
https://doi.org/10.1182/blood-2023-190640
Published: 2023
Journal Articles

Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children’s Oncology Group study AALL03N1 report

Clinical Trials & Observations
Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anna Hoppmann, Anne Angiolillo, David S. Dickens, Joseph P. Neglia, Yaddanapudi Ravindranath, A. Kim Ritchey, Amanda Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia
Journal: Blood
Blood (2023) 142 (3): 221–229.
https://doi.org/10.1182/blood.2023019631
Published: 2023
Includes: Supplemental data
Journal Articles

Ex Vivo Culture with Albumin Greatly Increases the Immunosuppressive Subset of T Lymphocytes

Jeong-A Kim, Jinhang Kim, Saetbyeol Kim, Misuk Yang, Youngrok Park, Jae-Yong Kwak
Journal: Blood
Blood (2022) 140 (Supplement 1): 4538–4539.
https://doi.org/10.1182/blood-2022-163010
Published: 2022
Journal Articles

A Multicenter Prospective Study for Validation of the Korean Simple Geriatric Assessment Tool in Elderly Patients with Multiple Myeloma

Ji Yun Lee, Soo-Mee Bang, Sang-A Kim, Youngil Koh, Ho-Young Yhim, Lee Gyeong-Won, Chang-Ki Min, Young Rok Do, Hyo Jung Kim, Sung Hwa Bae, Hyeon-Seok Eom, Je-Jung Lee, Hyunkyung Park, Seung-Hyun Nam, Ji Hyun Lee, Sung-Hyun Kim, Hyun Jung Lee, Min Kyoung Kim
Journal: Blood
Blood (2022) 140 (Supplement 1): 12501–12502.
https://doi.org/10.1182/blood-2022-165807
Published: 2022
Journal Articles

Preliminary Result of a Pilot Study of Apixaban in the Treatment of Splanchnic Vein Thrombosis

Sang-A Kim, Ji Yun Lee, Jeong-Ok Lee, Soo-Mee Bang
Journal: Blood
Blood (2022) 140 (Supplement 1): 5678–5679.
https://doi.org/10.1182/blood-2022-168446
Published: 2022
Journal Articles

Incidence of Skeletal-Related Events Among Multiple Myeloma Patients: A Nationwide Population-Based Cohort Study

Ji Yun Lee, Ju Hyun Lee, Sang-A Kim, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jeong-Ok Lee, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Jong-Seok Lee, Soo-Mee Bang, Eun Hee Jung, Minsu Kang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12570.
https://doi.org/10.1182/blood-2022-168747
Published: 2022
Journal Articles

Risk Stratification for Elderly Patients with Diffuse Large B-Cell Lymphoma Integrating Simplified Geriatric Assessment: A Prospective, Multicenter, Cohort Study

Ho-Young Yhim, Yong Park, Jeong-A Kim, Ho-Jin Shin, Young Rok Do, Joon Ho Moon, Min Kyoung Kim, Won Sik Lee, Dae Sik Kim, Myung-Won Lee, Yoon Seok Choi, Seong Hyun Jeong, Kyoung Ha Kim, Chang-Hoon Lee, Ga-Young Song, Jae-Yong Kwak, Deok-Hwan Yang
Journal: Blood
Blood (2022) 140 (Supplement 1): 6719–6720.
https://doi.org/10.1182/blood-2022-159929
Published: 2022
Journal Articles

A Pilot Study of MG4101, Allogeneic Natural Killer Cell, in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sang A Kim, Youngil Koh, Miyoung Jung, Yu Kyeong Hwang, Ja Min Byun, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung-Soo Yoon
Journal: Blood
Blood (2021) 138 (Supplement 1): 3835.
https://doi.org/10.1182/blood-2021-152137
Published: 2021
Journal Articles

Ex Vivo IL-2 Treatment Increases the Immunosuppressive Subset of T Lymphocytes to Suppress Allo-Immune Response

Jeong-A Kim, Jinhang KIM, Misuk Yang, Youngrok Park, Jae-Yong Kwak
Journal: Blood
Blood (2021) 138 (Supplement 1): 2066.
https://doi.org/10.1182/blood-2021-152462
Published: 2021
Journal Articles

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Clinical Trials & Observations
Lorenzo Falchi, Helen Ma, Sandra Klein, Jennifer K. Lue, Francesca Montanari, Enrica Marchi, Changchun Deng, Hye A. Kim, Aishling Rada, Alice T. Jacob, Cristina Kinahan, Mark M. Francescone, Craig R. Soderquist, David C. Park, Govind Bhagat, Renu Nandakumar, Daniel Menezes, Luigi Scotto, Lubomir Sokol, Andrei R. Shustov, Owen A. O’Connor
Journal: Blood
Blood (2021) 137 (16): 2161–2170.
https://doi.org/10.1182/blood.2020009004
Published: 2021
Includes: Supplemental data
Journal Articles

Second Imatinib Discontinuation Outcomes in Patients Regaining Durable Deep Molecular Response in the Korean Imatinib Discontinuation Study; KID Study

Sung-Eun Lee, MD PhD, Joon Seong Park, MD, Young Rok Do, PhDMD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MDPhD, Sukjoong Oh, MDPhD, Jae-Yong Kwak, Jeong-A Kim, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Dong-Wook Kim, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 51–52.
https://doi.org/10.1182/blood-2020-139253
Published: 2020
Journal Articles

Long-Term Outcomes of Chronic Myeloid Leukemia Patients Who Lost Undetectable Molecular Residual Disease (UMRD) after Imatinib Discontinuation: Korean Imatinib Discontinuation Study (KIDS)

Sung-Eun Lee, MD, Joon Seong Park, MD, Hyeoung-Joon Kim, MD PhD, Sung-Hyun Kim, MD PhD, Dae Young Zang, MD PhD, Sukjoong Oh, MD PhD, Young Rok Do, PhDMD, Yunsuk Choi, MD, Jae-Yong Kwak, MD PhD, Jeong-A Kim, MD PhD, Kyoo Hyung Lee, MD PhD, Yeung-Chul Mun, MD, Won Sik Lee, MD PhD, Myung Hee Chang, MD, Jinny Park, MD PhD, Jihyun Kwon, MD, Dong-Wook Kim
Journal: Blood
Blood (2019) 134 (Supplement_1): 1643.
https://doi.org/10.1182/blood-2019-126376
Published: 2019
Journal Articles

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Clinical Trials & Observations
Owen A. O’Connor, Lorenzo Falchi, Jennifer K. Lue, Enrica Marchi, Cristina Kinahan, Ahmed Sawas, Changchun Deng, Francesca Montanari, Jennifer E. Amengual, Hye A. Kim, Aishling M. Rada, Karen Khan, Alice T. Jacob, Michelle Malanga, Mark M. Francescone, Renu Nandakumar, Craig R. Soderquist, David C. Park, Govind Bhagat, Bin Cheng, Alberto Risueño, Daniel Menezes, Andrei R. Shustov, Lubomir Sokol, Luigi Scotto
Journal: Blood
Blood (2019) 134 (17): 1395–1405.
https://doi.org/10.1182/blood.2019001285
Published: 2019
Includes: Supplemental data
Journal Articles

Clinical Significance of Sex Chromosome Loss in Sex-Mismatched Bone Marrow Transplantations: A Potential Candidate for Predicting Adverse Prognosis

Joon Hee Lee, MD, Jong Do Seo, MD, Dajeong Jeong, MD, Jiwon Yun, MD, Sang-A Kim, MD, Dong-Yeop Shin, MD PhD, Sung-Soo Yoon, MD PhD, Dong Soon Lee, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3471.
https://doi.org/10.1182/blood-2018-99-118018
Published: 2018
Journal Articles

Pigment Epithelium-Derived Factor Promotes the Angiogenic Activity of VEGF

Jeong-A Kim, MD PhD, Misuk Yang, Young Hoon Park, MD, Youngrok Park, Jae-Yong Kwak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3687.
https://doi.org/10.1182/blood-2018-99-117420
Published: 2018
Journal Articles

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Young Rok Do, PhDMD, Jae-Yong Kwak, MD PhD, Hawk Kim, MDPhD, Jeong-A Kim, MD PhD, Hyeoung-Joon Kim, MD PhD, Joon Seong Park, MD, Jooseop Chung, MD PhD, Ho-Jin Shin, MD PhD, Sung-Hyun Kim, MD PhD, Udomsak Bunworasate, MD, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, MD, Dae Young Zang, MDPhD, Sukjoong Oh, MDPhD, Saengsuree Jootar, MD, Ary Harryanto Reksodiputro, MDPhD, Won-Sik Lee, MD, Yeung-Chul Mun, MD PhD, Jee Hyun Kong, MD, Priscilla B. Caguioa, MD, Jinny Park, MD PhD, Chul W. Jung, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2018-99-110568
Published: 2018
Journal Articles

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Clinical Trials & Observations
Jennifer E. Amengual, Renee Lichtenstein, Jennifer Lue, Ahmed Sawas, Changchun Deng, Emily Lichtenstein, Karen Khan, Laine Atkins, Aishling Rada, Hye A. Kim, Codruta Chiuzan, Matko Kalac, Enrica Marchi, Lorenzo Falchi, Mark A. Francescone, Lawrence Schwartz, Serge Cremers, Owen A. O’Connor
Journal: Blood
Blood (2018) 131 (4): 397–407.
https://doi.org/10.1182/blood-2017-09-806737
Published: 2018
Includes: Supplemental data
Journal Articles

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Young Rok Do, MD PhD, Hawk Kim, MD PhD, Jae-Yong Kwak, Jeong-A Kim, Hyeoung-Joon Kim, Joon Seong Park, MD, Jooseop Chung, MD PhD, Ho-Jin Shin, MD PhD, Sung-Hyun Kim, MD PhD, Udomsak Bunworasate, MD, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, MD, Dae Young Zang, Sukjoong Oh, Saengsuree Jootar, MD, Ary Harryanto Reksodiputro, MDPhD, Won-Sik Lee, MD, Yeung-Chul Mun, MD PhD, Jee Hyun Kong, Priscilla B. Caguioa, MD, Jinny Park, MD PhD, Chul W. Jung, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 317.
https://doi.org/10.1182/blood.V130.Suppl_1.317.317
Published: 2017